Literature DB >> 6804476

Seasonal variation of serum thyrotropin concentration and thyrotropin response to thyrotropin-releasing hormone in patients with primary hypothyroidism on constant replacement dosage of thyroxine.

N Konno, K Morikawa.   

Abstract

Ten patients with primary hypothyroidism (aged 32--66 yr), replaced on constant daily doses of L-T4 (mean +/- SD, 1.90 +/- 0.22 micrograms/kg BW), were used to examine seasonal variations in serum levels of thyroid-related hormones for a period of 14 months. Basal and peak TSH concentrations after TRH (500 micrograms) were higher in winter than in summer. Summer values for basal TSH were all normal (normal range, less than 4.8 microU/ml), while winter values were supranormal in 5 of 10 patients. Summer values for peak TSH were subnormal or normal (normal range, 5.0--40.0 microU/ml), while winter values were supranormal in 3 patients, with the remaining values being normal [log basal TSH, 0.511 +/- 0.438 vs. 0.084 +/- 0.244 (P less than 0.05); log peak TSH, 1.394 +/- 0.410 vs. 1.017 +/- 0.423 (P less than 0.05)]. Serum resin T3 uptake, T4, free T4 index(FT4I), T3, free T3 index, and rT3 levels did not vary seasonally, although T4 and FT4I tended to fall in the winter. The summer and winter QKd interval (the interval from the onset of a QRS complex in the electrocardiogram to the appearance of the Korotkoff sound at diastolic pressure), basal metabolic rate, and serum cholesterol concentrations were all within the normal range. Basal and peak TSH after TRH were inversely correlated with serum T4 and FT4I levels. The basal TSH concentration was further inversely correlated with the seasonally altering ambient temperature. These results indicate that during the treatment of primary hypothyroidism with constant doses of T4, 1) serum TSH and its response to TRH show seasonal variation, 2) the hypersecretion TSH in the winter is related to small changes in serum T4 and FT4I levels, and 3) the seasonal variation in the serum TSH concentration may need to be taken into consideration when evaluating the adequacy of a T4 replacement dose.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6804476     DOI: 10.1210/jcem-54-6-1118

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  TSH levels are associated with vitamin D status and seasonality in an adult population of euthyroid adults.

Authors:  I Barchetta; M G Baroni; F Leonetti; M De Bernardinis; L Bertoccini; M Fontana; E Mazzei; A Fraioli; M G Cavallo
Journal:  Clin Exp Med       Date:  2014-06-13       Impact factor: 3.984

2.  Measurements of serum-free thyroid hormone concentrations by ultrafiltration--a comparison with equilibrium dialysis and mathematical calculation.

Authors:  N Konno; K Hagiwara; H Taguchi; S Murakami; S Taguchi
Journal:  Ann Nucl Med       Date:  1987-09       Impact factor: 2.668

3.  Normal thyrotrophin response to intravenous thyrotrophin releasing hormone administration: the best index of optimal L-thyroxine therapy in primary hypothyroidism.

Authors:  U M Kabadi
Journal:  Postgrad Med J       Date:  1985-08       Impact factor: 2.401

4.  Semi-annual seasonal pattern of serum thyrotropin in adults.

Authors:  Daniele Santi; Giorgia Spaggiari; Giulia Brigante; Monica Setti; Simonetta Tagliavini; Tommaso Trenti; Manuela Simoni
Journal:  Sci Rep       Date:  2019-07-25       Impact factor: 4.379

Review 5.  Within-Person Variation in Serum Thyrotropin Concentrations: Main Sources, Potential Underlying Biological Mechanisms, and Clinical Implications.

Authors:  Evie van der Spoel; Ferdinand Roelfsema; Diana van Heemst
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-24       Impact factor: 5.555

6.  A Detailed Analysis of the Factors Influencing Neonatal TSH: Results From a 6-Year Congenital Hypothyroidism Screening Program.

Authors:  Giulia Di Dalmazi; Maria Assunta Carlucci; Daniela Semeraro; Cesidio Giuliani; Giorgio Napolitano; Patrizio Caturegli; Ines Bucci
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-17       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.